EMJ Podcast: Insights For Healthcare Professionals

Glenda Gray joins the EMJ Podcast for a quickfire discussion on antimicrobial resistance and child health. From antibiotic misconceptions to equitable access and stewardship, she shares sharp insights into why AMR is a defining global health challenge for children today.

Description: The final deep dive episode looks ahead: stem cells, tissue transplantation, fertility preservation in cancer care, and the policy challenges limiting access to advanced male infertility treatment. A future-facing discussion on cures and equity.

Timestamps: 00:00 – Introduction

01:02 – Stem cells

04:08 – Fertility preservation

05:04 – Access and cost

07:04 – Pricing variability

08:20 – What's next?

Description: In this second deep dive, Schlegel explains how microTESE transformed sperm retrieval. Learn how microsurgical precision improves outcomes, preserves testicular tissue, reduces pain, and why multidisciplinary collaboration drives high pregnancy rates.

Timestamps:00:00 – Introduction

01:06 – Why the microscope?

03:09 – MicroTESE advantages

04:11 – Success rates

06:29 – Postoperative care

08:04 – Multidisciplinary approaches

In this episode of Hema Now, Anna Schuh discusses the evolution of precision medicine in haematology. From her early inspiration to pursue haematology to her pioneering work in chronic lymphocytic leukaemia, she reflects on how whole genome sequencing, single-cell technologies, and circulating tumour DNA are transforming risk prediction and treatment strategies.

Timestamps:

00:00 – Introduction

02:20 – What drew Anna to haematology

03:57 – Chronic lymphocytic leukaemia

08:55 – Genomics reshaping high risk chronic lymphocytic leukaemia

12:19 – OxPLoreD and STELLAR aims

15:52 – Liquid biopsies

19:56 – Global diagnostics implementation challenges

25:57 – Integrating molecular testing clinically

29:20 – Training future precision leaders

33:51 – Next breakthroughs in precision haematology

35:35 – Three magic wishes

In this episode of Hema Now, Anna Schuh discusses the evolution of precision medicine in haematology. From her early inspiration to pursue haematology to her pioneering work in chronic lymphocytic leukaemia, she reflects on how whole genome sequencing, single-cell technologies, and circulating tumour DNA are transforming risk prediction and treatment strategies.

Timestamps:

00:00 – Introduction

02:20 – What drew Anna to haematology

03:57 – Chronic lymphocytic leukaemia

08:55 – Genomics reshaping high risk chronic lymphocytic leukaemia

12:19 – OxPLoreD and STELLAR aims

15:52 – Liquid biopsies

19:56 – Global diagnostics implementation challenges

25:57 – Integrating molecular testing clinically

29:20 – Training future precision leaders

33:51 – Next breakthroughs in precision haematology

35:35 – Three magic wishes

Description: In this first deep dive, Peter N. Schlegel joins host Catherine Glass to unpack non-obstructive azoospermia. Explore genetic discoveries, hormonal optimisation, age-related factors, and practical strategies that maximise sperm retrieval and conception potential.

Timestamps: 00:00 – Introduction

01:13 – Non-obstructive azoospermia

02:01 – Genetics of infertility

04:01 – Aromatase inhibitors

06:05 – Sperm quality

07:27 – Multiple semen samples

10:27 – Infertility globally

In this rapid-fire episode, Peter N. Schlegel answers key questions about male infertility, from what drives success in microTESE to the role of genetics, hormones, and surgical skill. A concise introduction to the science shaping modern men's reproductive care.

Bairey Merz discusses the latest directions in microvascular and endothelial research, including links to heart failure with preserved ejection fraction, integration of adverse pregnancy outcomes and autoimmune disease into models, and promising technological advances.

Timestamps:

00:53 – Directions of the WISE programme

01:47 – Preserved ejection fraction

04:51 – Adverse outcomes of microvascular disease

08:42 – Technology improving outcomes

This episode examines how diagnostic tools and imaging for microvascular dysfunction are evolving, the paradox of 'clear' arteries in symptomatic women, and barriers to broader implementation in clinical practice.

Timestamps:

00:45 – Angina in women

03:43 – Defining ischaemia

05:35 – Barriers to microvascular testing

In this episode of Onc Now, Kevin Harrington discusses the evolving landscape of head and neck cancer treatment, from the transformative impact of immunotherapy to the promise of oncolytic viruses. He reflects on the challenges that defined a decade of limited progress, the integration of radiotherapy and systemic therapies, and the importance of translating innovative science into clinical benefit. With insights into salivary gland cancers, combination strategies, and advice for the next generation of oncologists, this episode offers a comprehensive look at one of oncology's most rapidly advancing fields.

Timestamps:

00:00 – Introduction

01:10 – Specialisation in head and neck cancers

03:39 – Biggest challenges

06:30 – Impact of radiotherapy

11:19 – Role of systemic therapy

16:13 – Immunotherapy

21:10 – Salivary gland cancers

28:34 – Viruses as anti-cancer agents

33:22 – Translating innovative science

38:00 – Pairing viruses for certain cancers

41:47 – Advice to young oncologists

44:29 – Important breakthroughs

47:21 – Three magic wishes